(Q39830181)

15 September 2017

title

Gold (III) porphyrin complexes induce apoptosis and cell cycle arrest and inhibit tumor growth in colon cancer (English)

1 reference

15 September 2017

8

Chi-Ming Che

1 reference

15 September 2017

Shuiping Tu

1

1 reference

15 September 2017

Raymond Wai-Yin Sun

2

1 reference

15 September 2017

Marie C M Lin

3

1 reference

15 September 2017

Jian Tao Cui

4

1 reference

15 September 2017

Bing Zou

5

1 reference

15 September 2017

Qing Gu

6

1 reference

15 September 2017

Hsiang-Fu Kung

7

1 reference

15 September 2017

Benjamin C Y Wong

9

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 October 2009

1 reference

15 September 2017

1 reference

15 September 2017

volume

115

1 reference

15 September 2017

issue

19

1 reference

15 September 2017

page(s)

4459-4469

1 reference

Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip).

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24514

Adjuvant therapy of colon cancer: current status and future directions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24514

7 January 2021

Adjuvant therapy of colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24514

7 January 2021

Molecular mechanisms of resistance and toxicity associated with platinating agents

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24514

7 January 2021

Gold(III) complexes as potential antitumor agents: solution chemistry and cytotoxic properties of some selected gold(III) compounds

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24514

7 January 2021

Gold(III) complexes as a new family of cytotoxic and antitumor agents.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24514

7 January 2021

Gold(III) complexes with bipyridyl ligands: solution chemistry, cytotoxicity, and DNA binding properties

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24514

7 January 2021

Gold derivatives for the treatment of cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24514

7 January 2021

The history of gold therapy in rheumatoid disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24514

7 January 2021

Biological properties of two gold(III) complexes: AuCl3 (Hpm) and AuCl2 (pm)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24514

7 January 2021

Antitumor properties of some 2-[(dimethylamino)methyl]phenylgold(III) complexes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24514

7 January 2021

Gold(III) porphyrins as a new class of anticancer drugs: cytotoxicity, DNA binding and induction of apoptosis in human cervix epitheloid cancer cells.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24514

7 January 2021

Gold(III) Porphyrin 1a Induced Apoptosis by Mitochondrial Death Pathways Related to Reactive Oxygen Species

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24514

7 January 2021

Gold(III) compound is a novel chemocytotoxic agent for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24514

7 January 2021

Proteomic characterization of the cytotoxic mechanism of gold (III) porphyrin 1a, a potential anticancer drug

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24514

7 January 2021

Gene therapy for colon cancer by adeno-associated viral vector-mediated transfer of survivin Cys84Ala mutant.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24514

7 January 2021

Gold-based therapeutic agents

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24514

7 January 2021

A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24514

7 January 2021

Thioredoxin reductase and cancer cell growth inhibition by organogold(III) compounds

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24514

7 January 2021

Antitumor activity of platinum complexes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24514

7 January 2021

Interactions of Selected Gold(III) Complexes with Calf Thymus DNA

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24514

7 January 2021

Gold(III) dithiocarbamate derivatives for the treatment of cancer: solution chemistry, DNA binding, and hemolytic properties

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24514

7 January 2021

Mechanisms of cytotoxicity of selected organogold(III) compounds

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24514

7 January 2021

G1 arrest induction represents a critical determinant for cisplatin cytotoxicity in G1 checkpoint-retaining human cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24514

7 January 2021

p53 and p21 determine the sensitivity of noscapine-induced apoptosis in colon cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24514

7 January 2021

p53 downregulates expression of the G1/S cell cycle phosphatase Cdc25A.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24514

7 January 2021

Honokiol causes the p21WAF1-mediated G(1)-phase arrest of the cell cycle through inducing p38 mitogen activated protein kinase in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24514

7 January 2021

Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24514

7 January 2021

Identifiers

DOI

10.1002/CNCR.24514

1 reference

15 September 2017

1 reference